Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Crinetics Pharmaceuticals, Inc. (CRNX)  
$50.89 3.23 (6.78%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 73,491,000
Market Cap: 3.74(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $15.97 - $48.03
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Paltusotine is an oral selective nonpeptide somatostatin receptor type 2 agonists designed for the treatment of acromegaly and neuroendocrine tumors. CRN04777 is Co.'s investigational, oral, nonpeptide somatostatin receptor type 5 agonist designed for the treatment of congenital hyperinsulinism. CRN04894 is Co.'s investigational, oral, nonpeptide product candidate designed to antagonize adrenocorticotrophic hormone, or ACTH, intended for the treatment of diseases caused by excess ACTH.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 5,000 5,000
Total Buy Value $0 $0 $110,300 $110,300
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 187,216 236,174 574,096 633,966
Total Sell Value $8,508,936 $10,224,575 $19,214,235 $20,347,251
Total People Sold 6 7 8 8
Total Sell Transactions 7 15 23 39
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 182
  Page 2 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Betz Stephen F. Chief Scientific Officer   •       –      –    2024-03-04 4 A $0.00 $0 D/D 23,000 96,298     -
   Struthers Richard Scott President & CEO   •       •      –    2024-03-04 4 A $0.00 $0 D/D 65,000 250,522     -
   Struthers Richard Scott President & CEO   •       •      –    2024-02-12 4 GA $0.00 $0 I/I 60,000 110,000     -
   Struthers Richard Scott President & CEO   •       •      –    2024-02-12 4 GD $0.00 $0 I/I 60,000 570,805     -
   Betz Stephen F. Chief Scientific Officer   •       –      –    2024-01-25 4 AS $37.26 $111,780 D/D (3,000) 73,298 27%     
   Betz Stephen F. Chief Scientific Officer   •       –      –    2024-01-10 4 AS $37.65 $112,950 D/D (3,000) 76,298 26%     
   Pizzuti Dana Chief Med and Dev Officer   •       –      –    2024-01-03 4 AS $35.00 $503,125 D/D (14,375) 5,911 35%     
   Pizzuti Dana Chief Med and Dev Officer   •       –      –    2024-01-03 4 OE $16.89 $242,794 D/D 14,375 20,286     -
   Wilson Marc CFO   •       –      –    2024-01-02 4 AS $35.47 $354,700 D/D (10,000) 96,055 33%     
   Wilson Marc CFO   •       –      –    2024-01-02 4 OE $9.28 $92,800 D/D 10,000 106,055     -
   Betz Stephen F. Chief Scientific Officer   •       –      –    2023-12-26 4 AS $35.89 $107,670 D/D (3,000) 79,298 31%     
   Pizzuti Dana Chief Med and Dev Officer   •       –      –    2023-12-21 4 S $34.57 $331,284 D/D (9,583) 5,911 -36%     
   Pizzuti Dana Chief Med and Dev Officer   •       –      –    2023-12-21 4 OE $16.89 $161,857 D/D 9,583 15,494     -
   Betz Stephen F. Chief Scientific Officer   •       –      –    2023-12-11 4 AS $32.87 $98,610 D/D (3,000) 82,298 34%     
   Betz Stephen F. Chief Scientific Officer   •       –      –    2023-11-27 4 AS $31.84 $95,520 D/D (3,000) 85,298 46%     
   Struthers Richard Scott President & CEO   •       •      –    2023-11-09 4 OE $1.91 $95,500 D/D 50,000 185,522     -
   Struthers Richard Scott President & CEO   •       •      –    2023-11-03 4 S $30.56 $6,083,946 D/D (199,082) 135,522 -27%     
   Struthers Richard Scott President & CEO   •       •      –    2023-11-03 4 OE $9.28 $1,847,481 D/D 199,082 334,604     -
   Struthers Richard Scott President & CEO   •       •      –    2023-11-02 4 S $29.95 $27,494 D/D (918) 135,522 -31%     
   Struthers Richard Scott President & CEO   •       •      –    2023-11-02 4 OE $9.28 $8,519 D/D 918 136,440     -
   Krasner Alan Seth Chief Medical Officer   •       –      –    2023-10-17 4 S $30.00 $210,000 D/D (7,000) 43,210 -41%     
   Krasner Alan Seth Chief Medical Officer   •       –      –    2023-10-17 4 OE $12.01 $84,070 D/D 7,000 50,210     -
   Struthers Richard Scott President & CEO   •       •      –    2023-08-14 4 OE $1.91 $19,100 D/D 10,000 135,522     -
   Struthers Richard Scott President & CEO   •       •      –    2023-07-13 4 S $20.35 $288,095 I/I (14,157) 630,805 -46%     
   Struthers Richard Scott President & CEO   •       •      –    2023-07-12 4 S $20.17 $231,128 I/I (11,459) 644,962 -42%     
  182 Records found
  1  2  3  4  5  6  7  8   
  Page 2 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us